Payer+Provider's Health System Review
August 3, 2023
By targeting RNA rather than DNA, Amber Bio aims to treat multiple genetic diseases with fewer safety risks.
July 19, 2023
Surge Therapeutics is working on a treatment that, when applied during an operation, might help surgically-removed cancers from coming back.